Role of non-acid reflux in patients with non-erosive reflux disease

Annals of Gastroenterology

Volumn 26, Issue 2, 2013, Pages 100-103

  Karamanolis, Georgios P ^a   Tutuian, Radu ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Non acid reflux; Non erosive reflux disease

Indexed keywords

PROTON PUMP INHIBITOR;

ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; NON ACID REFLUX; NON EROSIVE REFLUX DISEASE; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION;

EID: 84876011026     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006;101:2128-2138
2. Savarino E, Zentilin P, Tutuian R, et al. The role of non-acid reflux in refining NERD: Lessons learned from impedancepH monitoring in 150 patients off therapy. Am J Gastroenterol 2008;103:2685-2693
3. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465
4. Smith JL, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989;96:683-689
5. DeMeester TR, Johnson LF, Joseph GJ, et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976;184:459-470
6. Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut 2006;55:313-318
7. Savarino E, Tutuian R, Zentelin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol 2010;105:1053- 1061
8. Van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetiks for gastroesophagel reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2006;3:CD002095
9. Watson RGP, Tham TCK, Johnston BT, et al. Double blind crossover placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux, the 'sensitive esophagus'. Gut 1997;40:587-590
10. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-545
11. Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010;32:334-343
12. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: Review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024- 1031
13. Singh S, Richter JE, Bradley LA, Haile JM. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993;38:1402-1408
14. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011;9:868-874
15. Sifrim D, Mittal R, Fass R, et al. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther 2007;25:1003-1005
16. Siddiqui A, Rodriguez-Stanley S, Zubaidi S, et al. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci 2005;50:81-85
17. Farre R, van Malenstein H, De Vos R, et al. Short exposure of oesophagel mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008;57:1366-1374
18. Bredenoord AJ, Weusten BL, Timmer R, et al. Characteristics of gastro-esophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 2006;101:2470-2475
19. Karamanolis G, Vanuytsel T, Sifrim D, et al. Yield of 24-hour esophageal pH and Bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci 2008;53:2387-2393
20. Gasiorowska A, Navarro-Rodriguez T, Wendel C, et al. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients ho failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol 2009;104:2005-2013
21. Takeda T, Nabae T, Kassab G, Liu J, Mittal RK. Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil 2004;16:721-728
22. Yang M, Li Z, Chen D, et al. Quantitative assessment and characterization of vis in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Clin J Pain 2010;26:326-331
23. Pandolfino JE, Shi G, Trueworthy B, et al. Esophagogastric junction opning during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology 2003;125:1018-1024
24. Pandolfino JE, Shi G, Curry J, et al. Esophagogastric junction distensibility: a factor contributing to sphincter incompetence. Am J Physiol Gastrointest Liver Physiol 2002;282:G1052-G1058
25. Bredenoord AJ. Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol 2012;107:8-15
26. Zerbib F, Duriez A, Roman S, Capdepont M, Mion F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008;57:156-160
27. Emerenziani S, Ribolsi M, Sifrim D, Blondeau K, Cicala M. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil 2009;21:235-238
28. Savarino E, Zentillin P, Tutuian R, et al. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol 2012;47:159-168
29. Savarino E, Marabotto E, Zentillin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011;43:542-547
30. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicenter study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-1402
31. Sharma N, Agrawal A, Freeman J, et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 2008;6:521-524
32. Zebrib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-1963
33. Viazis N, Keyoglou A, Kanellopoulos AK, et al. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: A placebo controlled study using esophageal pH-impedance monitoring. Am J Gastroenterol 2012;107:1662-1667
34. Fornari F, Blondeau K, Mertens V, Tack J, Sifrim D. Noctunal gastroesophageal reflux revisited by impedance-pH monitoring. J Neurogastroenterol Motil 2011;17:148-157
35. Poh CH, Allen L, Malagon I, et al. Riser's reflux-an eye-opening experience. Neurogastroentrol Motil 2010;22:387-394
36. Fiorucci S, Distrutti E, Di Matteo F, et al. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol 1995;90:270-276
37. Broeders JAJL, Bredenoord AJ, Hazebroek EJ, Broenders IAMJ, Gooszen HG, Smout AJPM. Effects of antireflux surgery on weakly acidic reflux and belching. Gut 2011;60:435-441
38. Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci 2001;56:1099-1106.